Doug Schenkel
Stock Analyst at Wolfe Research
(2.89)
# 1,519
Out of 5,138 analysts
70
Total ratings
53.85%
Success rate
34.12%
Average return
Main Sectors:
Stocks Rated by Doug Schenkel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BRKR Bruker | Upgrades: Outperform | $60 | $49.45 | +21.33% | 3 | Dec 10, 2025 | |
| WAT Waters | Upgrades: Outperform | $480 | $395.71 | +21.30% | 2 | Dec 10, 2025 | |
| GH Guardant Health | Upgrades: Outperform | $75 | $111.97 | -33.02% | 3 | Sep 25, 2025 | |
| CAI Caris Life Sciences | Initiates: Outperform | $32 | $27.00 | +18.52% | 1 | Jul 14, 2025 | |
| TEM Tempus AI | Initiates: Outperform | $60 | $69.15 | -13.23% | 1 | Dec 13, 2024 | |
| HOLX Hologic | Initiates: Peer Perform | n/a | $75.03 | - | 5 | Dec 13, 2024 | |
| TWST Twist Bioscience | Initiates: Outperform | $60 | $41.57 | +44.33% | 2 | Dec 13, 2024 | |
| STVN Stevanato Group | Initiates: Outperform | $28 | $21.02 | +33.24% | 1 | Dec 13, 2024 | |
| WST West Pharmaceutical Services | Initiates: Peer Perform | n/a | $280.52 | - | 1 | Dec 13, 2024 | |
| RGEN Repligen | Initiates: Peer Perform | n/a | $162.75 | - | 1 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $3.69 | - | 1 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $285 | $239.99 | +18.75% | 2 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $145.42 | - | 8 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $49 | $48.16 | +1.85% | 2 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $21.14 | - | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $145.83 | - | 5 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $102.42 | - | 4 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $626.14 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $6.12 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $115.30 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $2.29 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $12.05 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $242.01 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $5.15 | - | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $3.08 | - | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.49 | - | 1 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $5.53 | - | 1 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.89 | - | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $33.85 | - | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $18 | $1.79 | +908.40% | 1 | Jun 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $20.98 | - | 2 | Mar 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $90 | $286.15 | -68.55% | 2 | Feb 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $7.93 | - | 1 | Jan 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $187.82 | - | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $16 | $69.33 | -76.92% | 2 | Sep 28, 2017 |
Bruker
Dec 10, 2025
Upgrades: Outperform
Price Target: $60
Current: $49.45
Upside: +21.33%
Waters
Dec 10, 2025
Upgrades: Outperform
Price Target: $480
Current: $395.71
Upside: +21.30%
Guardant Health
Sep 25, 2025
Upgrades: Outperform
Price Target: $75
Current: $111.97
Upside: -33.02%
Caris Life Sciences
Jul 14, 2025
Initiates: Outperform
Price Target: $32
Current: $27.00
Upside: +18.52%
Tempus AI
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $69.15
Upside: -13.23%
Hologic
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $75.03
Upside: -
Twist Bioscience
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $41.57
Upside: +44.33%
Stevanato Group
Dec 13, 2024
Initiates: Outperform
Price Target: $28
Current: $21.02
Upside: +33.24%
West Pharmaceutical Services
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $280.52
Upside: -
Repligen
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $162.75
Upside: -
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $3.69
Upside: -
Oct 31, 2024
Upgrades: Outperform
Price Target: $285
Current: $239.99
Upside: +18.75%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $145.42
Upside: -
Jun 27, 2024
Upgrades: Outperform
Price Target: $49
Current: $48.16
Upside: +1.85%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $21.14
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $145.83
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $102.42
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $626.14
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $6.12
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $115.30
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $2.29
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $12.05
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $242.01
Upside: -
Aug 17, 2021
Initiates: Outperform
Price Target: n/a
Current: $5.15
Upside: -
Aug 16, 2021
Initiates: Market Perform
Price Target: n/a
Current: $3.08
Upside: -
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $3.49
Upside: -
Jan 12, 2021
Initiates: Outperform
Price Target: n/a
Current: $5.53
Upside: -
Dec 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $1.89
Upside: -
Jul 7, 2020
Initiates: Outperform
Price Target: n/a
Current: $33.85
Upside: -
Jun 19, 2018
Initiates: Outperform
Price Target: $18
Current: $1.79
Upside: +908.40%
Mar 28, 2018
Upgrades: Outperform
Price Target: n/a
Current: $20.98
Upside: -
Feb 22, 2018
Maintains: Outperform
Price Target: $80 → $90
Current: $286.15
Upside: -68.55%
Jan 2, 2018
Initiates: Outperform
Price Target: n/a
Current: $7.93
Upside: -
Nov 1, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $187.82
Upside: -
Sep 28, 2017
Maintains: Outperform
Price Target: $23 → $16
Current: $69.33
Upside: -76.92%